Pharmaceutical

BioVersys and GSK expand their partnership for TB treatment alpibectir

BioVersys and GSK have announced the expansion of their partnership to expedite the clinical development of alpibectir for tuberculosis (TB).

May 9, 2024 - 00:00
BioVersys and GSK expand their partnership for TB treatment alpibectir
BioVersys and GSK have announced the expansion of their partnership to expedite the clinical development of alpibectir for tuberculosis (TB).
Read the original article

Tags:

Previous Article

How six trends are driving pharmaceutical milling  

Next Article

TerSera’s ZOLADEX LA gains Health Canada approval for breast cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Opaque conflicts permeate prescription drug benefits; Sanofi prevails in Zantac arbitration

STAT+: Pharmalittle: Opaque conflicts permeate prescrip...

Jun 20, 2023

Suicide hotlines shared data with Facebook, providers debate AI disclosure, and Uber Health expands

Suicide hotlines shared data with Facebook, providers d...

Jun 14, 2023

First over-the-counter birth control pill in U.S. begins shipping to stores

First over-the-counter birth control pill in U.S. begin...

Mar 4, 2024